Logo
Pipeline
Pipeline

Primary medical focus of the company is arthritis and skin regeneration.

Carthronix is in the process of IND filing for a Phase 1-2A human clinical trial of our lead molecule in patients with osteoarthritis of knee. This trial will begin in early 2021. Our current pipeline also includes promising small molecules and revolutionary therapeutic peptides for complicated wound healing and fibrosis.

Current Pipeline